naloxone/oxycodone (Targiniq ER)

From Aaushi
Jump to navigation Jump to search

Indications

  • abuse-deterrent treatment for severe pain

Notes

  • deters abuse via injection and snorting, but it doesn't completely prevent it

More general terms

Components

References

  1. FDA News Release. July 23, 2014 FDA approves new extended-release oxycodone with abuse- deterrent properties. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm406407.htm